NEW YORK (360Dx) – T2 Biosystems reported after the market closed on Tuesday that its first quarter revenues rose 144 percent, beating the consensus Wall Street estimate.

For the three months ended March 31, 2018, the company posted revenues of $2.3 million, compared to $941,000 in the same period the year before. The analysts' average estimate was $1.5 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.